Metagenomi Therapeutics (MGX) Net Margin (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Net Margin of 1847.68% for Q1 2026, down 124096.0% year-over-year from N/an in Q1 2025, and down 220.77% quarter-over-quarter from 576.02% in Q4 2025.
Metagenomi Therapeutics (MGX) Net Margin (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 4 years of Net Margin data on file, last reported at 1847.68% in Q1 2026.
- Net Margin for Q1 2026 came in at 1847.68%, down 124096.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 384.61% (down 21240.0% YoY), and the FY2025 annual result was 348.54%, down 19928.0% from the prior year.
- Net Margin fell to 1847.68% in Q1 2026 per MGX's latest filing, from 576.02% in the prior quarter.
- Over five years, Net Margin peaked at 53.67% in Q2 2024 and troughed at 1847.68% in Q1 2026.
- A 4-year average of 369.4% and a median of 225.36% in 2024 frame the typical range for Net Margin.
- The sharpest annual moves came in 2024 and 2026: Net Margin surged 6107 bps in 2024, then sank 124096 bps in 2026.
- A 4-year view of Net Margin shows it stood at 155.61% in 2023, then slumped by 56 bps to 243.37% in 2024, then plunged by 137 bps to 576.02% in 2025, then sank by 221 bps to 1847.68% in 2026.
- Business Quant data shows MGX's Net Margin at 1847.68% in Q1 2026, 576.02% in Q4 2025, and 235.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - | -1,847.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,847.68% |
| Dec 31, 2025 | -576.02% |
| Sep 30, 2025 | -235.51% |
| Jun 30, 2025 | -233.85% |
| Mar 31, 2025 | -606.71% |
| Dec 31, 2024 | -243.37% |
| Sep 30, 2024 | -163.04% |
| Jun 30, 2024 | -53.67% |
| Mar 31, 2024 | -225.36% |
| Dec 31, 2023 | -155.61% |
| Sep 30, 2023 | -160.32% |
| Jun 30, 2023 | -114.74% |
| Mar 31, 2023 | -186.36% |